OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A narrative review about CDK4/6 inhibitors in the setting of drug resistance: updates on biomarkers and therapeutic strategies in breast cancer
Shidi Zhao, Haochen Zhang, Na Yang, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 6, pp. 1617-1634
Open Access | Times Cited: 12

Showing 12 citing articles:

Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Ilenia Pellarin, Alessandra Dall’Acqua, Andrea Favero, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 12

PIK Your Poison: The Effects of Combining PI3K and CDK Inhibitors against Metastatic Cutaneous Squamous Cell Carcinoma In Vitro
Jay R. Perry, Benjamin Genenger, Amarinder Singh Thind, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 370-370
Open Access | Times Cited: 4

Local Control of Advanced Breast Cancer—Debate in Multidisciplinary Tumor Board
Iuliana Pantelimon, Andra Maria Stancu, Simona Coniac, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 510-510
Open Access

Impact of cyclin dependent kinase 4/6 inhibitors on breast cancer brain metastasis outcomes
Sonya Chew, Emanuela Ferraro, Anton Safonov, et al.
European Journal of Cancer (2024) Vol. 207, pp. 114175-114175
Closed Access | Times Cited: 1

Palbociclib and letrozole for hormone receptor-positive HER2-negative breast cancer with residual disease after neoadjuvant chemotherapy
Sònia Pernas, Esther Sanfeliu, Guillermo Villacampa, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1

Efficacy and Safety of Abemaciclib in Combination With Endocrine Therapy for HR+/HER2− Advanced or Metastatic Breast Cancer
Zaheer Qureshi, Abdur Jamil, Eeshal Fatima, et al.
American Journal of Clinical Oncology (2024)
Closed Access

Double-Faced Immunological Effects of CDK4/6 Inhibitors on Cancer Treatment: Challenges and Perspectives
Yongqin Liu, Yujiao Deng, Chang Yang, et al.
Bioengineering (2024) Vol. 11, Iss. 11, pp. 1084-1084
Open Access

Aurora kinase A promotes trained immunity via regulation of endogenous S-adenosylmethionine metabolism
Mengyun Li, Xin Jin, Yongxiang Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1

Scroll to top